Terms: = Leukemia AND CSF3R, CD114, 1441, ENSG00000119535, GCSFR
280 results:
1. A Case of Chronic Eosinophilic leukemia with csf3r-Mutant Clone and Transformed to Secondary Acute Myeloid leukemia.
Wu Y; Yang X
Clin Lab; 2024 Apr; 70(4):. PubMed ID: 38623671
[TBL] [Abstract] [Full Text] [Related]
2. Atypical CML: diagnosis and treatment.
Breccia M
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):476-482. PubMed ID: 38066919
[TBL] [Abstract] [Full Text] [Related]
3. Germline
Bochicchio MT; Micucci G; Asioli S; Ghetti M; Simonetti G; Lucchesi A
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003211
[TBL] [Abstract] [Full Text] [Related]
4. Comprehensive genomic profiling reveals molecular subsets of
Johnson SM; Haberberger J; Galeotti J; Ramkissoon L; Coombs CC; Richardson DR; Foster MC; Duncan D; Montgomery ND; Ferguson NL; Zeidner JF
Leuk Lymphoma; 2024 Feb; 65(2):209-218. PubMed ID: 37921062
[TBL] [Abstract] [Full Text] [Related]
5. [Chronic neutrophilic leukemia/chronic eosinophilic leukemia].
Kawashima I; Kirito K
Rinsho Ketsueki; 2023; 64(10):1326-1334. PubMed ID: 37914248
[TBL] [Abstract] [Full Text] [Related]
6. Antineoplastic effects of pharmacological inhibitors of aurora kinases in csf3r
Parducci NS; Garnique ADMB; Lima K; Carlos JAEG; Fonseca NP; de Miranda LBL; de Almeida BO; Rego EM; Traina F; Machado-Neto JA
Blood Cells Mol Dis; 2024 Jan; 104():102799. PubMed ID: 37839173
[TBL] [Abstract] [Full Text] [Related]
7. [Granulocyte-colony stimulating factor-producing multiple myeloma presenting with neutrophilia].
Yokoi M; Kondo T; Shimizu R; Uchida K; Hayashi S; Nishimura H; Kondo E; Wada H
Rinsho Ketsueki; 2023; 64(8):735-740. PubMed ID: 37673624
[TBL] [Abstract] [Full Text] [Related]
8. [Analysis of
Cui M; Li QY; Lu XZ; Chao HY; Cai XH; Liu J; Hua HY; Wu P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):1019-1025. PubMed ID: 37551471
[TBL] [Abstract] [Full Text] [Related]
9. Germ line variants in patients with acute myeloid leukemia without a suspicion of hereditary hematologic malignancy syndrome.
Guijarro F; López-Guerra M; Morata J; Bataller A; Paz S; Cornet-Masana JM; Banús-Mulet A; Cuesta-Casanovas L; Carbó JM; Castaño-Díez S; Jiménez-Vicente C; Cortés-Bullich A; Triguero A; Martínez-Roca A; Esteban D; Gómez-Hernando M; Álamo Moreno JR; López-Oreja I; Garrote M; Risueño RM; Tonda R; Gut I; Colomer D; Díaz-Beya M; Esteve J
Blood Adv; 2023 Oct; 7(19):5799-5811. PubMed ID: 37450374
[TBL] [Abstract] [Full Text] [Related]
10. Identification of biomarkers related to sepsis diagnosis based on bioinformatics and machine learning and experimental verification.
Wang Q; Wang C; Zhang W; Tao Y; Guo J; Liu Y; Liu Z; Liu D; Mei J; Chen F
Front Immunol; 2023; 14():1087691. PubMed ID: 37449204
[TBL] [Abstract] [Full Text] [Related]
11. Chronic neutrophilic leukemia preceded by myelodysplastic syndromes.
Baba Y; Nakamaki T; Sakai H; Fukuchi K; Kabasawa N; Hattori N; Harada H
Int J Hematol; 2023 Nov; 118(5):636-641. PubMed ID: 37439996
[TBL] [Abstract] [Full Text] [Related]
12. csf3r-mutant chronic myelomonocytic leukemia is a distinct clinically subset with abysmal prognosis: a case report and systematic review of the literature.
Guastafierro V; Ubezio M; Manes N; Milanesi C; Della Porta M; Bonometti A
Leuk Lymphoma; 2023 Sep; 64(9):1566-1573. PubMed ID: 37395413
[TBL] [Abstract] [Full Text] [Related]
13. [Impact of
Li RQ; Wen XL; Zhang XL; Dong CX; Wang MF; Liu XX; Huang YJ; Tan YH; Chang JM; Zhang RJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):628-632. PubMed ID: 37356918
[TBL] [Abstract] [Full Text] [Related]
14. Mutational screens highlight glycosylation as a modulator of colony-stimulating factor 3 receptor (csf3r) activity.
Hollander MJ; Malaker SA; Riley NM; Perez I; Abney NM; Gray MA; Maxson JE; Cochran JR; Bertozzi CR
J Biol Chem; 2023 Jun; 299(6):104755. PubMed ID: 37116708
[TBL] [Abstract] [Full Text] [Related]
15. Integrated transcriptome, proteome and single-cell sequencing uncover the prognostic and immunological features of colony-stimulating factor 3 receptor in pan-cancer.
Song L; Jiang F; Tian Y; Cao X; Zhu M; Zhang J; Wang X; Deng L
J Gene Med; 2023 Oct; 25(10):e3508. PubMed ID: 36998239
[TBL] [Abstract] [Full Text] [Related]
16. ANKRD26 is a new regulator of type I cytokine receptor signaling in normal and pathological hematopoiesis.
Basso-Valentina F; Donada A; Manchev VT; Lisetto M; Balayn N; Martin JE; Muller D; Oyarzun CPM; Duparc H; Arkoun B; Cumin A; Faivre L; Droin N; Biunno I; Pecci A; Balduini A; Debili N; Antony-Debré I; Marty C; Vainchenker W; Plo I; Favier R; Raslova H
Haematologica; 2023 Aug; 108(8):2130-2145. PubMed ID: 36794499
[TBL] [Abstract] [Full Text] [Related]
17. [Restratifying the prognosis of acute myeloid leukemia patients with CEBPA double mutations based on csf3r mutations and measurable residual disease].
Su L; Tan YH; Lin H; Han W; Yang YP; Liu XL; Sun JN; Liu QJ; Gao SJ
Zhonghua Xue Ye Xue Za Zhi; 2022 Dec; 43(12):1021-1027. PubMed ID: 36709108
[No Abstract] [Full Text] [Related]
18. CNL and aCML should be considered as a single entity based on molecular profiles and outcomes.
Carreño-Tarragona G; Álvarez-Larrán A; Harrison C; Martínez-Ávila JC; Hernández-Boluda JC; Ferrer-Marín F; Radia DH; Mora E; Francis S; González-Martínez T; Goddard K; Pérez-Encinas M; Narayanan S; Raya JM; Singh V; Gutiérrez X; Toth P; Amat-Martínez P; Mcilwaine L; Alobaidi M; Mayani K; McGregor A; Stuckey R; Psaila B; Segura A; Alvares C; Davidson K; Osorio S; Cutting R; Sweeney CP; Rufián L; Moreno L; Cuenca I; Smith J; Morales ML; Gil-Manso R; Koutsavlis I; Wang L; Mead AJ; Rozman M; Martínez-López J; Ayala R; Cross NCP
Blood Adv; 2023 May; 7(9):1672-1681. PubMed ID: 36375042
[TBL] [Abstract] [Full Text] [Related]
19. Frequency and clinical impact of WT1 mutations in the context of CEBPA-mutated acute myeloid leukemia.
Wang T; Hua H; Wang Z; Wang B; Cao L; Qin W; Wu P; Cai X; Chao H; Lu X
Hematology; 2022 Dec; 27(1):994-1002. PubMed ID: 36066283
[TBL] [Abstract] [Full Text] [Related]
20. Alternatively spliced csf3r isoforms in SRSF2 P95H mutated myeloid neoplasms.
Wang BA; Mehta HM; Penumutchu SR; Tolbert BS; Cheng C; Kimmel M; Haferlach T; Maciejewski JP; Corey SJ
Leukemia; 2022 Oct; 36(10):2499-2508. PubMed ID: 35941213
[TBL] [Abstract] [Full Text] [Related]
[Next]
